Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Post by cleareyeon Jul 06, 2020 10:29pm
214 Views
Post# 31231932

Unique Low-Priced Gem Based on Fundamentals

Unique Low-Priced Gem Based on FundamentalsThis is a rare find.

Good revenue stream.

Float of a reasonable number of shares.

Improving EBITDA.

Close to break-even on earnings.

I hope they keep building their product line and distribution channels. The CIVID19 therapy opportunities may be exciting but I hope the company keeps its eye firmly on the ball representing their core non-COVID19 products.

If the share price were $1.20 it wouldn't surprise me. When I look at 6 cents I have to do a double-take.

May they continue to humbly and steadily build!
<< Previous
Bullboard Posts
Next >>